The global proteomics market size was estimated to be USD 25.92 billion in 2023 and is expected to reach at USD 111.99 billion by 2034 with a CAGR of 14.23% during the forecast period 2024-2034. Increasing demand for personalized medicines & advanced diagnostics, rising prevalence of target diseases, growing focus on drug designing, biomarker discoveries, & clinical diagnostics, surge in technological advancements, increasing funding for research & development activities, rising demand for tailored medication, growing prevalence of genetic illnesses & chronic diseases, surge in investments by major players for the development of advanced & effective drugs & diagnostic tools, and increasing launch of cutting-edge proteomics platforms are some of the key factors boosting the market growth.
Increasing launch of cutting-edge proteomics platforms is predicted to boost the market growth during the forecast period. Proteomics is well developed by incorporating several modern technologies, such as mass spectrometric analysis with high precision and sensitivity. For instance, in June 2023, Bruker Corporation has introduced a significant improvement in sensitivity for the 4D-Proteomics timsTOF platform through the introduction of the timsTOF Ultra mass spectrometer. In addition to an advanced 4th-generation TIMS (trapped ion mobility separation) XR cell, a 14-bit digitizer, and an upgraded Captive Spray Ionization (CSI) Ultra ion source with a bigger capillary and increased vortex gas flow, this most recent model also has other noteworthy characteristics.
By product, reagents & consumables was the highest revenue-grossing segment in the global proteomics market in 2023 owing to the widespread use of chemicals, strips, kits, reagents & consumables, and other materials for the analysis of diverse biological samples in research labs, academic institutions, and other settings. Additionally, instruments is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for automation in diagnostic techniques, surge in need for a cost-effective platform for sample analysis, rising focus on innovations & product development, increasing technological developments of advanced proteomics instruments such as 2-D electrophoresis protein analyzers, and growing collaborations within market players. For instance, in October 2022, A co-marketing collaboration between Agilent Technologies Inc. and CMP Scientific Corp. aims to provide a combined capillary electrophoresis-mass spectrometry (CS-MS) solution to meet the demands of the life science and pharmaceutical industries.
By application, clinical diagnostics was the highest revenue-grossing segment in the global proteomics market in 2023 owing to the identification of individual risk factors is highly prevalent among clinical researchers using protein analysis, rising demand for prevention & early intervention of the disease, surge in launch of advanced products, and increasing funding by major market players. For instance, in May 2022, Proteomics International Laboratories Ltd has secured $13,516 in funding to support the development of its PromarkerD clinical diagnostic test in Australia. This test is the world's initial predictive diagnostic tool for kidney disease associated with diabetes. The program aims to foster fresh healthcare advancements, progress findings towards confirming their feasibility and market viability in addressing significant health issues, and maximize entrepreneurial and innovative potential. Additionally, drug discovery is predicted to grow at fastest CAGR during the forecast period owing to the increasing focus on development of structure-based drug design, rising focus on developing medications that are more individualized, and growing investments in these areas.
By technology, spectroscopy was the highest revenue-grossing segment in the global proteomics market in 2023 owing to the increasing usage of spectroscopy-based technologies in numerous analytical applications, such as drug development processes, proteomics, metabolomics, forensic analysis, & pharmaceutical analysis, and growing launch of advanced products. For instance, For instance, in January 2022, Seer, Inc. has made two significant announcements: the full commercial launch of the Proteograph Product Suite and the introduction of the Centers of Excellence program. The Proteograph Product Suite provides unprecedented access to the proteome in an impartial manner. This innovative approach employs specially designed nanoparticles to create a groundbreaking product that facilitates large-scale proteomics analysis swiftly, comprehensively, and without bias. Additionally, microarray instruments is predicted to grow at fastest CAGR during the forecast period owing to the growing adoption of microarrays in various applications and surge in technological developments.
By end-user, pharmaceutical & biopharmaceutical companies was the highest revenue-grossing segment in the global proteomics market in 2023 owing to the increasing funding for research & development activities by major market players, growing launch of innovative products, and rising mergers & acquisitions within market player. For instance, in February 2023, Waters Corporation's acquisition of Wyatt Technology expands its Separation and Detection portfolio, offering customers an unparalleled range of analytical solutions for various applications. Additionally, academic & research institutes is predicted to grow at fastest CAGR during the forecast period owing to the rising focus on development of advanced proteomics platforms and surge in research & development activities.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing investments for the development of structure-based drug design, surge in research activities on omics, rising demand for superior research tools to ensure data repeatability, increasing focus on developing custom therapies, growing partnerships & collaborations within market players. For instance, in March 2022, Together with Symphogen, Thermo Fisher Scientific Inc. has developed verified platform processes that make it easier to characterize and evaluate the quality of complex therapeutic proteins. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising initiatives based on proteomics are being outsourced, increasing prevalence of target diseases, growing adoption of proteomics, surge in funding by government & private vendors, and rising research & development activities. For instance, in June 2022, Researchers at the Indian Institute of Science (IISc) in Bangalore have developed a new category of synthetic peptides, often referred to as mini-proteins, which they claim have the capability to render viruses like SARS-CoV-2 nonfunctional.
Increasing launch of cutting-edge proteomics platforms is predicted to boost the market growth during the forecast period. Proteomics is well developed by incorporating several modern technologies, such as mass spectrometric analysis with high precision and sensitivity. For instance, in June 2023, Bruker Corporation has introduced a significant improvement in sensitivity for the 4D-Proteomics timsTOF platform through the introduction of the timsTOF Ultra mass spectrometer. In addition to an advanced 4th-generation TIMS (trapped ion mobility separation) XR cell, a 14-bit digitizer, and an upgraded Captive Spray Ionization (CSI) Ultra ion source with a bigger capillary and increased vortex gas flow, this most recent model also has other noteworthy characteristics.
By product, reagents & consumables was the highest revenue-grossing segment in the global proteomics market in 2023 owing to the widespread use of chemicals, strips, kits, reagents & consumables, and other materials for the analysis of diverse biological samples in research labs, academic institutions, and other settings. Additionally, instruments is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for automation in diagnostic techniques, surge in need for a cost-effective platform for sample analysis, rising focus on innovations & product development, increasing technological developments of advanced proteomics instruments such as 2-D electrophoresis protein analyzers, and growing collaborations within market players. For instance, in October 2022, A co-marketing collaboration between Agilent Technologies Inc. and CMP Scientific Corp. aims to provide a combined capillary electrophoresis-mass spectrometry (CS-MS) solution to meet the demands of the life science and pharmaceutical industries.
By application, clinical diagnostics was the highest revenue-grossing segment in the global proteomics market in 2023 owing to the identification of individual risk factors is highly prevalent among clinical researchers using protein analysis, rising demand for prevention & early intervention of the disease, surge in launch of advanced products, and increasing funding by major market players. For instance, in May 2022, Proteomics International Laboratories Ltd has secured $13,516 in funding to support the development of its PromarkerD clinical diagnostic test in Australia. This test is the world's initial predictive diagnostic tool for kidney disease associated with diabetes. The program aims to foster fresh healthcare advancements, progress findings towards confirming their feasibility and market viability in addressing significant health issues, and maximize entrepreneurial and innovative potential. Additionally, drug discovery is predicted to grow at fastest CAGR during the forecast period owing to the increasing focus on development of structure-based drug design, rising focus on developing medications that are more individualized, and growing investments in these areas.
By technology, spectroscopy was the highest revenue-grossing segment in the global proteomics market in 2023 owing to the increasing usage of spectroscopy-based technologies in numerous analytical applications, such as drug development processes, proteomics, metabolomics, forensic analysis, & pharmaceutical analysis, and growing launch of advanced products. For instance, For instance, in January 2022, Seer, Inc. has made two significant announcements: the full commercial launch of the Proteograph Product Suite and the introduction of the Centers of Excellence program. The Proteograph Product Suite provides unprecedented access to the proteome in an impartial manner. This innovative approach employs specially designed nanoparticles to create a groundbreaking product that facilitates large-scale proteomics analysis swiftly, comprehensively, and without bias. Additionally, microarray instruments is predicted to grow at fastest CAGR during the forecast period owing to the growing adoption of microarrays in various applications and surge in technological developments.
By end-user, pharmaceutical & biopharmaceutical companies was the highest revenue-grossing segment in the global proteomics market in 2023 owing to the increasing funding for research & development activities by major market players, growing launch of innovative products, and rising mergers & acquisitions within market player. For instance, in February 2023, Waters Corporation's acquisition of Wyatt Technology expands its Separation and Detection portfolio, offering customers an unparalleled range of analytical solutions for various applications. Additionally, academic & research institutes is predicted to grow at fastest CAGR during the forecast period owing to the rising focus on development of advanced proteomics platforms and surge in research & development activities.
North America region is anticipated for the highest revenue share during the forecast period owing to the growing investments for the development of structure-based drug design, surge in research activities on omics, rising demand for superior research tools to ensure data repeatability, increasing focus on developing custom therapies, growing partnerships & collaborations within market players. For instance, in March 2022, Together with Symphogen, Thermo Fisher Scientific Inc. has developed verified platform processes that make it easier to characterize and evaluate the quality of complex therapeutic proteins. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising initiatives based on proteomics are being outsourced, increasing prevalence of target diseases, growing adoption of proteomics, surge in funding by government & private vendors, and rising research & development activities. For instance, in June 2022, Researchers at the Indian Institute of Science (IISc) in Bangalore have developed a new category of synthetic peptides, often referred to as mini-proteins, which they claim have the capability to render viruses like SARS-CoV-2 nonfunctional.
Segmentation: Proteomics Market Report 2022 - 2033
Proteomics Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Services
- Reagents & Consumables
- Instruments
Proteomics Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Clinical Diagnostics
- Drug Discovery
- Others
Proteomics Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
Electrophoresis
- Capillary Electrophoresis
- Gel Electrophoresis
Spectroscopy
- CD Spectrometry
- Mass Spectrometry
- NMR Spectrometry
Chromatography
- Ion Chromatography
- HPLC Chromatography
- Superficial Chromatography
- Affinity Chromatography
- X-Ray Crystallography
- Microarray Instruments
- Protein Fractionation Systems
- Surface Plasma Resonance (SPR) Systems
Proteomics Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Academic & Research Institutes
- Pharmaceutical & Biopharmaceutical Companies
- Laboratories
- Others
Proteomics Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Proteomics Market: Product Estimates & Trend Analysis
8. Proteomics Market: Application Estimates & Trend Analysis
9. Proteomics Market: Technology Estimates & Trend Analysis
10. Proteomics Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Proteomics Market
13. Europe Global Proteomics Market
14. Asia Pacific Global Proteomics Market
15. Latin America Global Proteomics Market
16. MEA Global Proteomics Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Agilent Technologies Inc.
- Waters Corporation
- Merck KGaA
- Bruker Corporation
- Bio-Rad Laboratories Inc
- Thermo Fisher Scientific Inc.
- Li-Cor Inc
- Danaher Corporation
- Horiba Ltd.
- Perkin Elmer Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 25.92 Billion |
| Forecasted Market Value ( USD | $ 111.99 Billion |
| Compound Annual Growth Rate | 14.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
